Latest News

• BYDUREON™ Safety and Tolerability Pooled Summary Data Presented at ADA 2010 Continue Reading »
• Alkermes Announces Notification of Tentative FDA Advisory Committee Meeting to Review VIVITROL® for Opioid Dependence Continue Reading »
• DURATION-4 Study Results: BYDUREON™ Efficacy and Tolerability Profile Extended to Monotherapy Treatment Continue Reading »